ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
The pharmacist warned that failure to pair the ... and potential kidney damage. Additionally, excessive intake may increase the risk of kidney stone formation and, in severe cases, lead to vitamin D ...